CRP Rapid Quantitative Test - India CDSCO Medical Device Registration

CRP Rapid Quantitative Test is a medical device registered with India's Central Drugs Standard Control Organization (CDSCO) under UID IMP/IVD/2020/000278_36b9d76978b5275b7f9b27dc2d352407_34585f39e7034a27fef9393af8944c96. This device is marketed under the brand name CEA. The license holder is RAPID DIAGNOSTIC PVT. LTD., and it is classified as Device Class Class C. The approving authority is CDSCO.

This page provides comprehensive regulatory information including complete registration details, license holder information, device classification, and related products. Pure Global AI offers free access to 71,807+ India medical device registrations, helping global MedTech companies identify partners, analyze markets, and discover business opportunities efficiently.

Free Database

CDSCO Registered

Class Class C

CRP Rapid Quantitative Test

UID: IMP/IVD/2020/000278_36b9d76978b5275b7f9b27dc2d352407_34585f39e7034a27fef9393af8944c96

Brand Name

CEA

License Holder

RAPID DIAGNOSTIC PVT. LTD.

Device Class

Class C

Approving Authority

CDSCO

Product Information

Quantitative determination of CRP in human whole blood, serum or plasma. The test is used as an aid to predict future cardiovascular diseases (CEA) as well as to see infection and inflammation